Corrigendum.
In the White Paper by Benno Ingelse, Begona Barroso, Nicholas Gray, Verena Jakob-Rodamer, Clare Kingsley, Corinna Sykora, Petra Vinck, Martina Wein & Stephen White, ‘European Bioanalysis Forum: recommendation on dealing with hemolyzed and hyperlipidemic matrice.’ Bioanalysis 6(23), 3113–3120 (2014), a reference was missed out. The newly added reference is [24], added on page 3116 at the end of the following sentence: ‘Regarding the bioanalytical field, there is no consensus about the definition of hyperlipidemic plasma as there is no commercially available source of standardized hyperlipidemic matrix [24].’ And the reference is as follows: Mayrand-Provencher L, Furtado M, Mess J-N, Dumont I, Garofolo F. Choosing the appropriate matrix to perform a scientifically meaningful lipemic plasma test in bioanalytical method validation. Bioanalysis 6(12), 1639–1646 (2014). The editors of Bioanalysis would like to sincerely apologize for any inconvenience or confusion this may have caused our readers.